How Genetic Testing Unlocks Hidden Cancer Risks in Families
How Genetic Testing Unlocks Hidden Cancer Risks in Families
How Genetic Testing Unlocks Hidden Cancer Risks in Families
Cancer development is often linked to genetic abnormalities, suggesting a hereditary risk in many cases. Experts now estimate that 60–80% of a patient’s likelihood of developing certain diseases may stem from genetic factors. Yet identifying the exact genes responsible remains a challenge in some situations. Cancer begins when cells acquire genetic mutations, some of which can be inherited. Medical guidelines now recommend genetic testing for nearly all cancer types to assess individual risk. In Vladivostok, these tests are carried out at the Primorsky Regional Oncology Dispensary.
A medical geneticist evaluates a patient’s risk by reviewing their medical history and family background. If similar cases appear in relatives, a genetic link becomes more likely. However, not all conditions have clear genetic markers—some are certain to develop, while others depend on probability alone. In Russia, genetic testing for cancer is fully covered under the mandatory health insurance system. This ensures wider access to risk assessments. Still, the final likelihood of disease depends on multiple factors, not just a single mutation.
Genetic testing provides valuable insights into cancer risk, with hereditary factors playing a major role in many cases. While some mutations guarantee illness, others only increase probability. The process combines medical history, family patterns, and genetic data to form a personalised risk profile.